Daunomycin- And adriamycin-N-(2-hydroxypropyl)methacrylamide Copolymer Conjugates; Toxicity Reduction by Improved Drug-Delivery

Cancer Treat Rev. 1987 Dec;14(3-4):319-27. doi: 10.1016/0305-7372(87)90024-7.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents / toxicity*
  • Chemical Phenomena
  • Chemistry
  • Daunorubicin / therapeutic use
  • Daunorubicin / toxicity*
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Doxorubicin / toxicity
  • Drug Carriers
  • Leukemia L1210 / drug therapy
  • Mice
  • Polymethacrylic Acids / therapeutic use
  • Polymethacrylic Acids / toxicity*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Polymethacrylic Acids
  • daunomycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugate
  • doxorubicin-N-(2-hydroxypropyl)methacrylamide copolymer conjugate
  • Doxorubicin
  • Daunorubicin